Albar Capital’s Medtronic MDT Stock Holding History

Albar Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,895	Closed	-$1.14M	–	51
2023 Q2	$1.14M	Buy	+12,895	New	+$1.11M	0.25%	32

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Albar Capital's MDT Position: Q3 2023 in Review

Albar Capital sold out of Medtronic (MDT) in Q3 2023, closing a stake of 12,895 shares — an estimated $1.14M sold.

Albar Capital first reported a position in MDT in Q2 2023 and held it in 1 quarter. The position peaked at $1.14M in Q2 2023. 1,971 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Albar Capital reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
Albar Capital sold 12,895 Medtronic shares in Q3 2023, an estimated $1.14M.
Albar Capital first reported a position in Medtronic in Q2 2023 and held it in 1 quarter.
Albar Capital's Medtronic position peaked at $1.14M in Q2 2023.
1,971 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Albar Capital's 13F filing for Q3 2023, filed 14 Nov 2023.